Sleep AI is building the world's largest sleep intelligence platform, with over a billion hours of sleep data, connections to more than a million users, and 100+ published studies. The company operates a B2B model providing sleep data infrastructure through three channels: R&D services for product validation, reimbursed digital therapeutics in Germany's healthcare system, and SDK/API partnerships that embed sleep intelligence into health apps. In a recent episode of BUILDERS, I sat down with Colin Lawlor, CEO and Founder of Sleep AI, to learn how the company transitioned from eight years of deep R&D to active commercialization and their strategy to reach a billion people through partnership distribution.
Topics Discussed:
The $100 billion sleep market's validation gap: only 300 of 10,000 sleep products have scientific measurement
Sleep AI's data collection engine: half a million data points per user annually from phones, wearables, and predictive models
Germany's regulatory breakthrough: achieving full reimbursement for 74 million people without prescription requirements
The device-agnostic platform strategy connecting to any data source to maximize distribution reach
Transitioning from pure R&D focus to building sales, marketing, and PR functions for the first time
GTM Lessons For B2B Founders:
Time product-market readiness against defensible data moats, not funding cycles: Colin invested 8-9 years collecting a billion hours of sleep data and publishing 100+ studies before scaling commercialization. This created inbound demand from companies with unsolved problems and established technical credibility that competitors can't replicate quickly. For deep-tech B2B founders, premature go-to-market before achieving technical differentiation means competing on sales execution rather than product superiority. The German reimbursement approval—a multi-year regulatory process requiring robust clinical evidence—exemplifies outcomes only accessible with patience.
Collapse the technical-commercial divide by embedding experts in revenue processes: Sleep AI's scientists participate in sales conversations from initial discovery through close. This isn't consultation—it's full integration. The cultural frame Colin established: "innovation and scientific breakthroughs are great if they have an impact, but if they stay in a box...they have no impact." For technical founders, this means your PhD-level team must own customer outcomes, not just product capabilities. If your best technical minds aren't in customer conversations, you're leaving competitive advantage on the table.
Position as infrastructure when solving complex, multi-intervention problems: Colin recognized no single company can solve sleep comprehensively—it requires medical diagnosis, environmental optimization, behavioral coaching, and product interventions. Rather than attempting vertical integration, Sleep AI built horizontal infrastructure (SDK/API) that makes other health companies better. The insight: "We want to reach a billion people through the companies that they already trust by being their trusted sleep partner." Infrastructure plays generate winner-take-most outcomes in fragmented markets where solution complexity exceeds any single vendor's scope.
//
Sponsors:
Front Lines — We help B2B tech companies launch, manage, and grow podcasts that drive demand, awareness, and thought leadership. www.FrontLines.io
The Global Talent Co. — We help tech startups find, vet, hire, pay, and retain amazing marketing talent that costs 50-70% less than the US & Europe. www.GlobalTalent.co
//
Don't Miss: New Podcast Series — How I Hire
Senior GTM leaders share the tactical hiring frameworks they use to build winning revenue teams. Hosted by Andy Mowat, who scaled 4 unicorns from $10M to $100M+ ARR and launched Whispered to help executives find their next role.
Subscribe here: https://open.spotify.com/show/53yCHlPfLSMFimtv0riPyM
Weitere Episoden von „BUILDERS“



Verpasse keine Episode von “BUILDERS” und abonniere ihn in der kostenlosen GetPodcast App.








